Literature DB >> 19869057

IMMUNOLOGICAL REACTIONS OF THE ISOLATED CARBOHYDRATE AND PROTEIN OF PNEUMOCOCCUS.

O T Avery1, H J Morgan.   

Abstract

The data presented in this paper clearly indicate that the isolated carbohydrate and nucleoprotein constituents of Pneumococcus differ both serologically and antigenically one from the other. Moreover, each of these fractions of the cell separately exhibits immunological properties distinct from those manifested by the whole organism of which they form a part. The carbohydrate is a protein-free polysaccharide and as such is devoid of the property of stimulating antibodies. Although in the free state, dissociated from other cellular substances, it is non-antigenic, in this form it still retains the property of reacting specifically in anti-pneumococcus serum of the homologous type. Further, this nonprotein constituent is not reactive with antiprotein serum. In other words, neither pneumococcus carbohydrate nor protein as separate antigen gives rise to antibodies with specific affinities for the carbohydrate or so called soluble specific substance of Pneumococcus. The nucleoprotein of Pneumococcus, on the other hand, is antigenic. Immunization with this cell constituent gives rise to immune serum which precipitates solutions of pneumococcus protein without regard to the type from which it is derived. The interrelations of the carbohydrate and protein of Pneumococcus as they exist in the intact cell to form the complete antigen, and the interpretation of the differences in the antigenic properties of the whole bacterium as contrasted with those of its component parts are reserved for discussion in a subsequent paper.

Entities:  

Year:  1925        PMID: 19869057      PMCID: PMC2131013          DOI: 10.1084/jem.42.3.347

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : SECOND PAPER.

Authors:  M Heidelberger; O T Avery
Journal:  J Exp Med       Date:  1924-08-31       Impact factor: 14.307

2.  IMMUNOLOGICAL RELATIONSHIPS OF CELL CONSTITUENTS OF PNEUMOCOCCUS.

Authors:  O T Avery; M Heidelberger
Journal:  J Exp Med       Date:  1923-06-30       Impact factor: 14.307

3.  THE ANTIGENIC PROPERTIES OF SOLUTIONS OF PNEUMOCOCCUS.

Authors:  O T Avery; J M Neill
Journal:  J Exp Med       Date:  1925-08-31       Impact factor: 14.307

  3 in total
  27 in total

1.  A brief history of pneumococcal vaccines.

Authors:  R Austrian
Journal:  Drugs Aging       Date:  1999       Impact factor: 3.923

2.  SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS.

Authors:  W S Tillett; T Francis
Journal:  J Exp Med       Date:  1930-09-30       Impact factor: 14.307

3.  ANTIPNEUMOCOCCIC IMMUNITY REACTIONS IN INDIVIDUALS OF DIFFERENT AGES.

Authors:  W D Sutliff; M Finland
Journal:  J Exp Med       Date:  1932-05-31       Impact factor: 14.307

4.  Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types.

Authors:  S C Szu; S Clarke; J B Robbins
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

5.  ON PRECIPITABLE SUBSTANCES DERIVED FROM BACILLUS TYPHOSUS AND BACILLUS PARATYPHOSUS B.

Authors:  J Furth; K Landsteiner
Journal:  J Exp Med       Date:  1928-01-01       Impact factor: 14.307

6.  IMMUNOLOGICAL PROPERTIES OF A TYPICAL (S-PRODUCING) AND A DEGRADED (NON-S-PRODUCING) STRAIN OF TYPE II PNEUMOCOCCUS WITH SPECIAL REFERENCE TO PROTECTIVE ANTIBODIES.

Authors:  E L Gaspari; W L Fleming; J M Neill
Journal:  J Exp Med       Date:  1927-06-30       Impact factor: 14.307

7.  SPECIFIC ANTIBODY RESPONSE OF HUMAN SUBJECTS TO INTRACUTANEOUS INJECTION OF PNEUMOCOCCUS PRODUCTS.

Authors:  M Finland; W D Sutliff
Journal:  J Exp Med       Date:  1932-05-31       Impact factor: 14.307

8.  THE RELATION OF THE CAPSULAR SUBSTANCE OF B. COLI TO ANTIBODY PRODUCTION.

Authors:  T Smith
Journal:  J Exp Med       Date:  1928-08-31       Impact factor: 14.307

9.  STUDIES ON THE OXIDATION AND REDUCTION OF IMMUNOLOGICAL SUBSTANCES : X. IMMUNOLOGICAL DISTINCTIONS BETWEEN THE HEMOTOXIN AND THE "PROTEIN FRACTION" OF THE PNEUMOCOCCUS CELL.

Authors:  J M Neill; W L Fleming; E L Gaspari
Journal:  J Exp Med       Date:  1927-10-31       Impact factor: 14.307

10.  CUTANEOUS REACTIONS IN PNEUMONIA. THE DEVELOPMENT OF ANTIBODIES FOLLOWING THE INTRADERMAL INJECTION OF TYPE-SPECIFIC POLYSACCHARIDE.

Authors:  T Francis; W S Tillett
Journal:  J Exp Med       Date:  1930-09-30       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.